LEVOSALBUTAMOL HYDROCHLORIDE 1.25MG & BUDESONIDE INHALATION SUSPENSION 0.5MG Manufacturer, Supplier, Franchise in India
The combination of Levosalbutamol Hydrochloride 1.25 mg and Budesonide 0.5 mg in an inhalation suspension is used for the management of respiratory conditions particularly asthma and chronic obstructive pulmonary disease (COPD)
Indications for BUTACARE-L Suspension
Chronic Asthma: BUTACARE-L is indicated for the maintenance treatment of asthma in adults and children, providing both bronchodilation and anti-inflammatory effects to improve overall control of the condition.
Acute Asthma Exacerbations: It can be used for the relief of acute symptoms during asthma attacks, helping to open the airways and reduce inflammation.
Chronic Obstructive Pulmonary Disease (COPD):
Maintenance Therapy: The combination is indicated for the management of COPD, alleviating symptoms such as wheezing, shortness of breath, and coughing. It helps to improve lung function and quality of life for individuals with this chronic condition.
Prevention of COPD Exacerbations: Regular use can help reduce the frequency of COPD exacerbations, contributing to better long-term management.
Exercise-Induced Bronchospasm: BUTACARE-L Suspension may be effective in preventing bronchospasm induced by exercise, allowing individuals to engage in more physical activities with less risk of respiratory issues.